Xact Kapitalforvaltning’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Xact Kapitalforvaltning’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,844	Closed	-$567K	–	1445
2019 Q3	$567K	Hold	5,844	–	–	0.01%	845
2019 Q2	$598K	Hold	5,844	–	–	0.01%	823
2019 Q1	$666K	Hold	5,844	–	–	0.02%	751
2018 Q4	$229K	Hold	5,844	–	–	0.01%	1383
2018 Q3	$319K	Buy	5,844 +700	+14%	+$47.9K	0.01%	1327
2018 Q2	$426K	Buy	5,144 +500	+11%	+$38.6K	0.01%	1063
2018 Q1	$309K	Buy	4,644 +600	+15%	+$34.6K	0.01%	1227
2017 Q4	$208K	Buy	+4,044	New	+$291K	0.01%	1229

Xact Kapitalforvaltning's ONCE Position: Q4 2019 in Review

Xact Kapitalforvaltning sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 5,844 shares — an estimated $567K sold.

Xact Kapitalforvaltning first reported a position in ONCE in Q4 2017 and held it in 8 quarters. The position peaked at $666K in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Xact Kapitalforvaltning reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Xact Kapitalforvaltning sold 5,844 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $567K.
Xact Kapitalforvaltning first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
Xact Kapitalforvaltning's Spark Therapeutics, Inc. Common Stock position peaked at $666K in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Xact Kapitalforvaltning's 13F filing for Q4 2019, filed 14 Feb 2020.